DDDD.L Share Chat (DDDD)

If there is funding in place for 12 months I can see a bit of a bounce in the short term. However:-

a. The BOD’s needs to be replaced to get some trust back in the Company. How much has this Admin process cost the company and shareholders..

b. A timeline of expected results over the next 12 months needs to be issued and clear. Otherwise come 12 months the fear of further dilution will further impact the share price.

I am however glad that the company isn’t being wound up - so credit to those that have come up with the new funding - albeight at our expense.

As before I will keep for 6 months and review then.

My guess is anything between 5-15p until we get some further news, or further dilution!

More like rise to ~8p+, as 12 month cash runway in place, further updates due. Would not be surprised if we hit double figs fairly quickly. Noted value of peers in this space, we are cheap....

Perhaps they are but it doesnt make them wrong! Duncan has a value for the company, just not the face of it.

Someone on LSE is clearly ****ed off with Duncan presenting for the company. I found the following post there today:
______________________________________________________________________________________________

I don't often post here, but thought this was worth sharing. I found it in a Telegram group I am part of.

It's a Petition to ask the board to stop Duncan presenting on behalf of the company as he's crap at it. TBH I completely agree he's crap at this role and I've signed it. It is all anonymous / separate from any account IDs. It reads:

We, the below, petition the board of 4D Pharma Plc as follows:

Over the last two years Duncan has been provided with feedback following some very poor and flawed presentations. In particular it focused on his presentational style, poor lighting/acoustics and general image. In addition, Duncan has been unable to present the value proposition and investment case of 4D concisely. Many times Duncan's ad-hoc and rambling presentation style has led to potentially misleading statements being made and lack of clarity. The feedback asked him to improve this significantly. In the opinion of the petitioners rather than making improvements Duncan has gone backward in this regard and should no longer be the public face of the company to investors and the market in general.

The following link will take you directly to the petition where you need only to add your Shareholder name.

hxxps://forms.office.com/e/2h6Dmvs8r3

It is otherwise anonymous and there is no connection to your user id.

5p likely. 4p very possible. Madness that we are here after so much promise. Management should be ashamed of themselves but will no doubt keep leeching a decent salary from shareholders.

sinking swiftly to 5p and bouncing around until the next RNS and then.......

I know , you’d have thought he’d learnt a lesson … but noooo.

Yes the BS has started, more BS to come,

"...take off"

Lol. Rather optimistic! But I'm with you Porky - fingers crossed!

RNS 30/12/22:-

As soon as practicable following passing of the Resolutions at the General Meeting, the Joint Administrators intend to make an application to the court to be listed for a hearing on an urgent basis to approve the Company's exit from administration. Provided the court approves the listing on an urgent basis, it is expected that the hearing will be within approximately two weeks of passing on the Resolutions. Should the court approve the exit from administration, the Joint Administrators will vacate ofce (and the Board of Directors will resume their full authority) following receipt and nalisation of the court order which would be expected to be within two days of the court hearing.

Resolutions passed on 16th Jan 23 so now just waiting on a court date to relist and go live. Must be getting close now. Good Luck

That's the score Wasps beat Zebre in 2016, it must be an omen.......we're about to get stung!

14 - 82? Yours!!

II has for months had it flipping to having the 16.3p value or 0 value, sometimes showing SP changes. I assume the system struggles with this scenario (it really shouldn't).

82p will do for me

Perhaps I haven't been paying enough attention but today on Interactive Investor I notice than instead of zero value during the trading day it now states a 14p/82p spread ?

It’s way too early to have any idea what the price will be. If the relist comes with some great data on MRX0518, positive updates on the vaccine collab with Merk then people will be all over this share. It’s all about progress now- let’s hope some has been made over the past 7 months

Sorry to hear. It did go pop rather quickly!

Hope you get at least some of it back!

Michael
Good points . Caution needed here. We are in a nest of vipers out for their own gain and DP is unquestionnably one of them. I am more critical than you. I believe this was a set up after the spike failed to allow a Placing. I think the s/p will be played like a harp 4-8p and we will get nowhere. But it is a penny or two better than liquidity. Lost a fortune here.

You know the resolutions were passed right?

We're now waiting for DDDD to give the new investors a load of very cheap shares to cover their £15m interest, which will dictate what level these should be at, and then they should be coming back to market. Current thinking is something around the 5-7p level...

Extract from the December 30th RNS

"If the Resolutions are not passed by the close of business on 20 January 2023, the conditions underlying the Financing Package will not be met and the Financing Package will not be secured by the Company. In the absence of the Fundraising, the Company has no other viable options and as no alternative sources of funding are available, the consequence of the Fundraising not being consummated would be that the Company would have to cease trading, and proceed to an insolvent liquidation of the Company yielding a zero (or a near zero) return to Shareholders."

So after close of business today, they will update on the position going forward, presumably Monday or Tuesday next week?

It Is currently looking like 6p open however, we don’t know what other funds especially recovery funds are going to buy in and also before the collapse the shorting book which added to the companies demise was absolutely horrendous, it was one of the most shorted stocks on the market.

I am not sure how short positions stand when stocks are suspended but clearly if the shorts are still active they will need closing as such if this listed at 6p it will rally fairly quickly with shorts closing. Wouldn’t surprise me if this one opens and settles close to where it it got suspended around 16p - interesting to see

To relist, the business must have enough working capital for one year as such as I had totally written this one off I will just leave in the bottom draw.

Might be true and honestly not talking the price up or down. I have a plan for either eventuality. Thoughts are that I’ve seen prices dip below raise prices before and it may happen here…. Or may not. Who knows.

Just had a look at Armistice capital and can u believe they had at the back end of 2022……$ 5.7 billion under their management and here’s what they’re all about …
Armistice Capital is a global, long/short, value-oriented, and event driven hedge fund manager, based in New York. It was founded in July 2012 by Steven Boyd, a former analyst at Senator Investment Group.

The firm's strategy focuses primarily on the healthcare and consumer sectors and invests predominantly in equities but can be opportunistic across the capital structure. It seeks to maximize the opportunity set of investment candidates allowing for the selection of unique, concentrated bets to generate uncorrelated returns. The firm maintains a significant position and portfolio-level hedges in an effort to mitigate basis and market risks. It views its strategy as the marriage of value and event and aims to produce consistent, risk-adjusted returns in all markets.

Boyd began his career as a consultant at McKinsey & Co after graduating from the Wharton School of the University of Pennsylvania in 2003. He later worked as a healthcare analyst at Scott Bommer's SAB Capital before joining event driven hedge fund, York Capital Management, in 2007.

So This debt buyout of 4d and the W/C investment they’re making here is clearly something they see value in 4sure (it most certainly is at what they’re paying tbf) but if u take a look at their portfolio under management it’s a pretty diversified spread over the full healthcare spectrum. I admit to knowing Jack about them b4 the last Rns but I just can’t see them jumping in here without being pretty sure they are going to get a significant return on their investment but I guess I would say that being a 4d advocate myself . Finally as I’ve said b4 I get why folk are clamouring for a change in the BOD but I’m pretty sure that 4d was the original brainchild of DP &AS so I can’t see them going anywhere myself except leaving the business /finance side to someone far more competent than they are and certainly more competent than the last CFO they employed ..now he was sh@te .
Let’s hope we get some science updates very soon GLA

Lets face it our new shareholders are getting in at the bottom, I expect upward movement, why else invest £Ms

I would be surprised if it didn't touch 6p or lower at some point soon after opening. What it will open at though, who knows.